Gunja N, Collins M, Graudins A (2004). “A comparison of the pharmacokinetics of oral and sublingual cyproheptadine”. Journal of Toxicology. Clinical Toxicology42 (1): 79–83. doi:10.1081/clt-120028749. PMID15083941.
Gupta, S; Popli, A; Bathurst, E; Hennig, L; Droney, T; Keller, P (May 1998). “Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder”. Comprehensive Psychiatry39 (3): 160–4. doi:10.1016/S0010-440X(98)90076-1. ISSN0010-440X. PMID9606583.
Gillman PK (1999). “The serotonin syndrome and its treatment”. Journal of Psychopharmacology (Oxford, England)13 (1): 100–9. doi:10.1177/026988119901300111. PMID10221364.
Silver, H; Blacker, M; Weller, MPI; Lerer, B (February 1989). “Treatment of chronic schizophrenia with cyproheptadine”. Biological Psychiatry25 (4). doi:10.1016/0006-3223(89)90206-0.
Rosskamp RH, Haverkamp F, von Kalckreuth G (May 1990). “The effect of cyproheptadine on plasma growth hormone (GH) and on somatostatin response to GH-releasing hormone in man”. Horm. Metab. Res.22 (5): 295–7. doi:10.1055/s-2007-1004905. PMID1971804.
Gunja N, Collins M, Graudins A (2004). “A comparison of the pharmacokinetics of oral and sublingual cyproheptadine”. Journal of Toxicology. Clinical Toxicology42 (1): 79–83. doi:10.1081/clt-120028749. PMID15083941.
Gupta, S; Popli, A; Bathurst, E; Hennig, L; Droney, T; Keller, P (May 1998). “Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder”. Comprehensive Psychiatry39 (3): 160–4. doi:10.1016/S0010-440X(98)90076-1. ISSN0010-440X. PMID9606583.
Mills KC (October 1995). “Serotonin syndrome”. American Family Physician52 (5): 1475–82. PMID7572570.
Gillman PK (1999). “The serotonin syndrome and its treatment”. Journal of Psychopharmacology (Oxford, England)13 (1): 100–9. doi:10.1177/026988119901300111. PMID10221364.
Rosskamp RH, Haverkamp F, von Kalckreuth G (May 1990). “The effect of cyproheptadine on plasma growth hormone (GH) and on somatostatin response to GH-releasing hormone in man”. Horm. Metab. Res.22 (5): 295–7. doi:10.1055/s-2007-1004905. PMID1971804.
Roth BL, Driscol J (12 January 2011). “PDSP Ki Database”. Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. 26 October 2013閲覧。